The stimulatory and inhibitory components of cocaine's actions on the 5-HTP-induced 5-HT(2A) receptor response

Pharmacology Biochemistry and Behavior

Volumn 55, Issue 3, 1996, Pages 387-396

  Darmani, Nissar A ^a   Reeves, Sharon L ^a  

^a A T STILL UNIVERSITY   (United States)

Author keywords

5 HT(2A) receptor; 5 Hydroxytryptophan; Cocaine; GBR 12935; Head twitch response; S( ) UH 301; Sertraline; WIN 35428; Yohimbine

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; 2 DIPROPYLAMINO 5 FLUORO 8 HYDROXYTETRALIN; 3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; 5 HYDROXYTRYPTOPHAN; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CARBIDOPA; COCAINE; DOPAMINE UPTAKE INHIBITOR; NISOXETINE; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TROPANE DERIVATIVE; YOHIMBINE;

AMINE TRANSPORT; ANIMAL EXPERIMENT; BEHAVIOR; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENTIATION; HEAD TWITCH; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALIA;

EID: 0030297077     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00108-6     Document Type: Article

References (61)

1. 1. Bedard, P.; Pycock, C. J. Wet-dog shake behaviour in the rat: A possible quantitative model of central 5-hydroxytryptamine activity. Neuropharmacology 16:663-670; 1977.
2. 2A receptor in vivo. Soc. Neurosci. Abstr. 20:P1546; 1994.
3. 3. Björk, L.; Cornfield, L. J.; Nelson, D. L.; Hillver, S.-E.; Andén, N. E,; Lewander, T.; Hacksell, U. Pharmacology of the novel 5-hydroxytryptamine 1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: Inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects. J. Pharmacol. Exp. Ther. 258:58-65; 1991.
4. 4. Broderick, P. A. Cocaine: On-line analysis of an accumbens amine neural basis for psychomotor behavior. Pharmacol. Biochem. Behav. 40:959-968; 1991.
5. 5. Carroll, M. E.; Lac, S. T.; Asencio, M.; Kargh, R. Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 35:237-244; 1990.
6. 6. Carroll, M. E.; Lac, S. T.; Asencio, M.; Kargh, R. Intravenous cocaine self-administration in rats is reduced by dietary tryptophan. Psychopharmacology (Berlin) 100:239-300; 1990.
7. 7. Chen, N.-H.; Reith, M. E. A. Effects of locally applied cocaine, lidocaine and various uptake blockers on monamine transmission in the ventral tegmental area of freely moving rats: A microdialysis study on monoamine interrelationships. J. Neurochem. 63:1701-1713; 1994.
8. 8. Clark, R. L.; Daum, S. J.; Gambino, A. J.; Aceto, M. D.; Pearl, J.; Levitt, M.; Cumiskey, W. R.; Bogado, E. F. Compounds affecting the central nervous system: 4,3 β-phenyltropane-2-carboxylic esters and analogs. J. Med. Chem. 16:1260-1267; 1973.
9. 9. Corne, S. J.; Pickering, R. W.; Warner, B. T. A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Br. J. Pharmacol. 20:106-120; 1963.
10. 10. Cunningham, K. A.; Lakoski, J. M. The interaction of cocaine with serotonin dorsal raphe neurons. Single unit extracellular recording studies. Neuropsychopharmacology 3:41-50; 1990.
11. 2-receptor supersensitive mice. Pharmacol. Biochem. Behav. 45:269-274; 1993.
12. 12. Darmani, N. A. The effects of acute cocaine administration on the DOI-induced head-twitch response in reserpinized mice. Pharmacol. Biochem. Behav. 49:229-232; 1994.
13. 2-receptor function. Pharmacol. Biochem. Behav. 41:519-527; 1992.
14. 2 receptors? Pharmacol. Biochem. Behav. 36:901-906; 1990.
15. 1A receptors. Pharmacol. Biochem. Behav. 38:353-357; 1991.
16. 1A receptor antagonist S(-)UH 301 produces head-twitches in mice. Pharmacol. Biochem. Behav. (in press).
17. 2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine. Pharmacol. Biochem. Behav. 49:107-113; 1994.
18. 18. Friedman, E.; Gershon, S.; Rotrosen, J. Effects of acute cocaine treatment on the turnover of 5-hydroxytryptamine in the rat brain. Br. J. Pharmacol. 54:61-64; 1975.
19. 19. Fuller, R. W. Uptake inhibitors increase extracellular serotonin measured by brain microdialysis. Life Sci. 55:163-167; 1994.
20. 20. Galloway, M. P. Regulation of dopamine and serotonin synthesis by acute administration of cocaine. Synapse 6:63-72; 1990.
21. 21. Gartside, S. E.; Cowen, P. J.; Sharp, T. Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis. Neuropharmacology 31:9-14; 1992.
22. 22. Glennon, R. A.; Lucki, I. Behavioural models of serotonin receptor activation. In: Sanders-Bush, E., ed. Serotonin. Clifton Park, NJ: Humana Press; 1988:253-294.
23. 2 receptors. Br. J. Pharmacol. 84:743-753; 1985.
24. 24. Guerin, G. F.; Crow, C.; Cunningham, K. A.; Goeders, N. E. Effects of trazodone in intravenous cocaine self-administration in rats. Soc. Neurosci. Abs. 18:P724; 1992.
25. 25. Handley, S. L.; Singh, L. Neurotransmitters and shaking behaviour: More than a "gut bath" for the brain. Trends Pharmacol. Sci. 7:324-328; 1986.
26. 2-adrenoceptors. Psychopharmacology (Berlin) 88:320-324; 1986.
27. 27. Hartvig, P.; Tedroff, J.; Linder, K. J.; Bjurling, P.; Chang, C-W.; Tsukada, H.; Watanabe, Y.; Lanström, B. Positron emission tomographic studies on aromatic L-amino acid decarboxylase activity in vivo for L-dopa and 5-hydroxy-L-tryptophan in the monkey brain. J. Neural Transm. 94:127-135; 1993.
28. 2-mediated head-twitch response in mice: Possible implications for the actions of antidepressant drugs. Psychopharmacology (Berlin) 89:414-420; 1986.
29. 1B autoreceptor blocking properties of the β-adrenoceptor antagonist (-) penbutolol. J. Pharmacol. Exp. Ther. 265:707-712; 1993.
30. 30. Humphrey, P. P. A.; Hartig, P.; Hoyer, D. A. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 14:233-236; 1993.
31. 31. Invernizzi, R.; Belli, S.; Samanin, R. An increase of extracellular serotonin in dorsal raphe masks the effect of sertraline in frontal cortex. In: Rollema, H.; Westerink, B.; Drijfhout, W. J., eds. Monetering molecules in neuroscience. Groningen: University Centre for Pharmacy; 1991:253-255.
32. 32. Knapp, S.; Mandell, A. J. Narcotic drugs: Effects on the serotonin biosynthetic systems of the brain. Science 177:1209-1211; 1972.
33. 33. Koe, B. K.; Weissman, A.; Welch, W. M.; Brown, R. G. Sertraline, 1S, 4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin. J. Pharmacol. Exp. Ther. 226:686-700; 1983.
34. 34. Kuhar, M. J.; Ritz, M. C.; Grigoriadis, D.; Lew, R.; Sharkey, J. A cocaine receptor associated with dopamine transport and drug self-administration. In: Lakoski, J. M.; Galloway, M. P.; White, F. J., eds. Cocaine, pharmacology, physiology and clinical strategies. Boca Raton, FL: CRC Press; 1992:191-201.
35. 35. Lacey, M. G.; Mercuri, N. B.; North, R. A. Actions of cocaine on rat dopaminergic neurons in vitro. Br. J. Pharmacol. 99:731-735; 1990.
36. 36. Lakoski, J. M.; Cunningham, K. A. Cocaine interactions with central monoaminergic systems. Electrophysiological approaches. Trends Pharmacol. Sci. 9:177-180; 1988.
37. 37. Loh, E. A.; Roberts, D. C. S. Break-point on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology (Berlin) 101:262-266; 1990.
38. 38. Lucki, I.; Nobler, M. S.; Frazer, A. Differential actions of serotonin antagonists on two behavioural models of serotonin receptor activation in the rat. J. Pharmacol. Exp. Ther. 228:133-139; 1984.
39. 39. Mattia, A.; Lecesse; A. P.; Morton, J. E. Effects of qupazine on cocaine self-administration in rats. Pharmacologist 28:151-156; 1986.
40. 2 antagonist, attenuates craving for cocaine by rats. Pharmacol. Biochem. Behav. 46:125-129; 1993.
41. 41. Meert, T. F.; Janssen, P. A. J. Ritanserin, a new therapeutic approach for drug abuse. Part 2: Effects on cocaine. Drug Dev. Res. 25:39-53; 1992.
42. 42. Murdoch, D.; McTavish, D. Sertraline: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder. Drugs 44:604-624; 1992.
43. 43. Nunes, E. V.; Rosecan, J. S. Human neurobiology of cocaine. In: Spitz, H. I.; Rosecan, J. S., eds. Cocaine abuse, new directions in treatment and research. New York: Brunnel/Mazel; 1987:48-62.
44. 44. O'Niel, M.; Page, N.; Adkins, W. N.; Eichelman, B. Tryptophantrazodone treatment of aggressive behavior. Lancet 2:859-860; 1986.
45. 45. Pan, Z. Z.; Williams, J. T. Differential actions of cocaine and amphetamine on dorsal raphe neurons in vitro. J. Pharmacol. Exp. Ther. 251:56-62; 1989.
46. 46. Reith, M. E. A.; de Costa, B.; Rice, K. C.; Jacobson, A. E. Evidence for mutually exclusive binding of cocaine, BTCP, GBR 12935, and dopamine to the dopamine transporter. Eur. J. Pharmacol. 227:417-425; 1992.
47. 3H-batrachotoxin A 20-α-benzoate binding sites on sodium channels in mouse brain synaptosomes. J. Biol. Chem. 261:7300-7305; 1986.
48. 48. Reith, M. E. A.; Meisler, B. E.; Sershen, H.; Lajtha, A. Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem. Pharmacol. 35:1123-1129; 1986.
49. 49. Richardson, N. R.; Roberts, D. C. S. Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine-self-administration in the rat. Life Sci. 49:833-840; 1991.
50. 50. Richelson, E.; Pfenning, M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes. Most antidepressants selectively block norepinephrine uptake. Eur. J. Pharmacol. 104:277-286; 1984.
51. 51. Ritz, M. C.; Lamb, R. J.; Goldberg, S. R.; Kuhar, M. J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223; 1987.
52. 52. Rowbotham, M. C.; Jones, R. T.; Benowitz, N. L.; Jacob, P. Trazodone - Oral cocaine interactions. Arch Gen. Psychiatry 41:895-899; 1984.
53. 53. Sanders-Bush, E.; Burris, K. D.; Knoth, K. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonsits at serotonin receptors linked to phosphoinostide hydrolysis. J. Pharmacol. Exp. Ther. 246:924-928; 1988.
54. 1A agonists. J. Pharmacol. Exp. Ther. 273:101-112; 1995.
55. 55. Surprenant, A.; Williams, J. T. Inhibitory synaptic potentials recorded from mammalian neurons prolonged by blockade of noradrenaline uptake. J. Physiol. 382:87-103; 1987.
56. 56. Tadano, T.; Satoh, S.-E.; Satoh, N.; Kisara, K.; Arai, Y.; Kim, S. K.; Kinemuchi, H. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain. J. Pharmacol. Exp. Ther. 250:254-260; 1989.
57. 2-Adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo. Naunyn Schmiedebergs Arch Pharmacol. 345:137-143; 1992.
58. 3H-nisoxetine: A new radioligand for norepinephrine uptake sites in brain. Eur. J. Pharmacol. 191:239-243; 1990.
59. 59. Tutton, C. S.; Crayton, J. W. Current pharmacotherapies for cocaine abuse: A review. J. Addict. Dis. 12:109-127; 1993.
60. 60. Van der Zee, P.; Koger, H. S.; Gootges, J.; Hespe, W. Aryl 1,4-dialk(en)yl-piperazines are selective and very potent inhibitors of dopamine uptake. Eur. J. Med. Chem. 15:363-369; 1980.
61. 61. Williams, J. T.; Lacey, M. G. Actions of cocaine on central monoamine neurons: Intracellular recording in vitro. Res. Mongr. Natl. Inst. Drug Abuse 90:234-242; 1989.